Daily BriefsEvent-Driven

Daily Brief Event-Driven: 2023 JPX Nikkei 400 Rebal – 38 IN and more

In today’s briefing:

  • 2023 JPX Nikkei 400 Rebal – 38 IN, 36 OUT, 4.2% One Way Flow
  • Kenedix Merger: Big Passive Inflows on the Cards
  • Toshiba (6502) Tender Offer – Kioxia Optionality
  • Zomato Lock-Up – A US$650m+ Worth Acquisition Linked Lockup Release
  • EOFLOW/Medtronic Tender: Insulet’s US Complaint Materially Increases Deal Break Risks
  • KKR/OHB: Agreed Take-Private Offer
  • What Is KDB’s Plan B for Asiana Airlines?
  • InvoCare (IVC AU): SID Signed with TPG at A$12.7/Share


2023 JPX Nikkei 400 Rebal – 38 IN, 36 OUT, 4.2% One Way Flow

By Travis Lundy

  • The Tenth Annual JPX Nikkei 400 Index Review was announced on Monday 7 August. There are 38 Inclusions, 36 Deletions. They are mostly in line with Janaghan Jeyakumar, CFA‘s predictions.
  • The BIG SELL is T&D Holdings (8795 JP), which surprised me. The top BUY is ROHM Co Ltd (6963 JP) which was not on the Quiddity Leaderboard.
  • Otherwise, the ADDs and DELETEs are 1.8-2.0 days of ADV, there are several NEW CAPs and some RECAPS among LARGE CAPS

Kenedix Merger: Big Passive Inflows on the Cards

By Brian Freitas


Toshiba (6502) Tender Offer – Kioxia Optionality

By Travis Lundy

  • Yesterday, JIP finally announced its Tender Offer for Toshiba Corp (6502 JP) as discussed in JIP Tender Offer for Toshiba (6502) Finally Here 
  • I got a few questions this morning on the earnings call comments from Chairman Watanabe regarding what might happen if a Kioxia Transaction were announced mid-JIP Tender.
  • My assumption before, during, and after, is that the Board wants this deal done. And doesn’t really want to take any responsibility for pushing any more.

Zomato Lock-Up – A US$650m+ Worth Acquisition Linked Lockup Release

By Sumeet Singh

  • In Aug 2022, Zomato completed the acquisition of Blinkit’s outstanding shares via issuing its own shares. These issued shares will come up for lockup release on 10th Aug 2023.
  • Zomato is one of two leading food delivery app operators in India. Its acquisition of Blinkit marked its foray into the instant grocery segment.
  • In this note, we will talk about the lock-up dynamics and recent updates.

EOFLOW/Medtronic Tender: Insulet’s US Complaint Materially Increases Deal Break Risks

By Arun George


KKR/OHB: Agreed Take-Private Offer

By Jesus Rodriguez Aguilar

  • KKR’s launching a cash offer for space tech firm OHB SE (OHB GR) at €44/share, 37% premium, 8.1x EV/Fwd NTM EBITDA, 16.1x Fwd P/E for an implied equity value of c.€769 million.
  • The Fuchs family will retain its majority shareholding. OHB’s strong balance sheet might be leveraged to further consolidate the industry. The offer price seems slightly cheap but not outrageous.
  • I believe a price hike is unlikely. Gross spread is 3.75%. Considering a break of €32.2, the market is pricing an 86% probability of success. I’d be long the shares.

What Is KDB’s Plan B for Asiana Airlines?

By Douglas Kim

  • There have been increasing local news flows about KDB’s potential “Plan B” for Asiana Airlines in case the merger between Asiana Airlines and Korean Air Lines is finally cancelled.
  • The final decisions by the European and US regulators on whether to pass/block this merger are likely to take place in 4Q 2023. 
  • The higher probability scenarios are for one or both of these regulators to block this deal. As such, KDB will need to come up with Plan B.

InvoCare (IVC AU): SID Signed with TPG at A$12.7/Share

By Brian Freitas

  • Invocare has entered into a scheme implementation deed with TPG at A$12.7/share. This is higher than the initial offer of A$12.65/share but lower than the revised offer of A$13/share.
  • There is an extra A$0.26/share in franking credits for Invocare Ltd (IVC AU) shareholders that can use them.
  • Passives will need to sell nearly 11m shares of Invocare Ltd (IVC AU) on the last trading day and there will be an adhoc inclusion to the S&P/ASX 200 Index.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars